UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934


      Date of Report (Date of earliest event reported): November 21, 2007
                     -----------------------------------------------------------


                              POSSIS MEDICAL, INC.
- --------------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)


      Minnesota                       0-944                41-0783184
- --------------------------------------------------------------------------------
(State or other jurisdiction (Commission File Number)     (IRS Employer
   of incorporation)                                     Identification No.)



9055 Evergreen Boulevard NW, Minneapolis, MN               55433-8003
- --------------------------------------------------------------------------------
(Address of principal executive offices)                   (Zip Code)


Registrant's telephone number, including area code 763-780-4555
                                                   -----------------------------


                                 Not Applicable
- --------------------------------------------------------------------------------
         (Former name or former address, if changed since last report.)


Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

[_]  Written communications pursuant to Rule 425 under the Securities Act (17
     CFR 230.425)

[_]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
     240.14a-12)

[_]  Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17 CFR 240.14d-2(b))

[_]  Pre-commencement communications pursuant to Rule 13e-4(c) under the
     Exchange Act (17 CFR 240.13e-4(c))






      Section 9 - Financial Statements and Exhibits

            Item 9.01 Possis Medical, Inc., Reports Quarterly Financial Results

On November 21, 2007, the Company issued a press release reporting operating
results for its fiscal year 2008 first quarter ending October 31, 2007. A copy
of the press release is furnished as Exhibit 99.1 to this Report and is
incorporated herein by reference.

    [c]   Exhibits

99.1      Press Release, dated November 21, 2007, issued by Possis Medical, Inc.



                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

 Possis Medical, Inc.
 --------------------
 (Registrant)

Date:  November 21, 2007
       -----------------


By:     /s/ Jules L. Fisher
        -------------------
            Jules L. Fisher
            Vice President, Finance and Chief Financial Officer






                                  EXHIBIT INDEX

Exhibit No.     Description
- -----------     -----------

99.1            Press Release, dated November 21, 2007, issued by
                Possis Medical, Inc.